Do not administer within 48 hr before or 2 wk after administration of intranasal influenza virus vaccine ( FluMist ).
Consider available information on influenza drug susceptibility patterns and treatment effects before using rimantadine.
PO: Do not administer last dose of medication near bedtime; this drug may produce insomnia in some patients.
Advise patient to take medication as directed at evenly spaced times for full course of therapy, even if feeling well. Take missed doses as soon as possible unless almost time for next dose; do not double up on missed doses.
May cause dizziness. Advise patient to avoid driving or other activities that require alertness until response to the drug is known.
Advise patient to consult health care professional about receiving a flu vaccination.
Inform patient that frequent mouth rinses, good oral hygiene, and sugarless gum or candy may decrease dry mouth.
Advise patient to consult health care professional before taking OTC medications or herbal products, especially aspirin or acetaminophen, or drinking alcoholic beverages.
Instruct patient and family to notify health care professional if influenza symptoms occur.
Avoidance of or reduction in symptoms associated with influenza A infection.
riMANTAdine is a sample topic from the Davis's Drug Guide.
Davis’s Drug Guide App + Web powered by Unbound Medicine provides up-to-date information on 5000+ trade name and generic drugs. View on the web or download App to your iPhone, iPad, or Android smartphone or tablet. Davis Drug Guide PDF. Learn more.